ELSAma

FULL M&A

ELS Solutions executes the steps of the Mergers & Acquisitions process for pharmaceutical assets and the health and well-being industry, from the diagnosis and execution of the asset assessment process to the completion of the business and consequent follow-up.

Whether you are seeking to sell, acquire or optimize the performance of a middle market enterprise there is really only one place you can go to reliably realize superior results: ELS Solutions Group.

A totally client-centric organization laser focused on intimately understanding our client’s unique needs and mission critical objectives.

When you elect to engage ELS Solutions Group you are engaging a state-of-the-art, resource empowered organization where your dedicated M&A Advisor serves as an organizational maestro directing and coordinating action plans that get you to where you want to go.

1. Technical-Centric

We don’t mean only from a financial point-of-view. We are financial healthcare and pharmaceutical experts. But we blend it in an unique set of attributes and skills with our state-of-the-art scientific skills level with decades of experience in pharmaceuticals and healthcare businesses. With PhDs and MBA combo, ELS Solutions Group provides a unique set of experience to bring your safely land your dream deal.

2. Personalized

Every engagement is unique and requires unique handling. Our philosophy is all about personalized client services and professionals you trust to act solely in our client’s best interest.

3. Confidential

We are very rigorous about protecting the confidentiality of our client’s business initiatives and their information which we guard with the utmost vigilance.

4. Value-Driven

We further concentrate on assisting our client’s to fully and intelligently understand value dynamics and enterprise valuation to eliminate guesswork and unrealistic expectations.

5. Results-Driven

We take an honest, straight-forward, candid, professional partnership approach tilted toward under-promising and over-delivering.

6. Customer and people centric

Where the M&A world at times becomes fixated on revenues, EBITDA multiples, compounded annual growth rates, which are important and serve their purpose, ELS Solutions Group realizes it’s really all about people, their pride in what they have created, their underlying motives and what they actually endeavoring to achieve.

7. Clear and action-oriented

We Listen and understand our client’s objectives, concerns, sensitivities, vision and prioritized goals. We simplify the complex. We cooperatively share our expertise, wisdom gained over the years to provide fresh, objective insight and advice. We formulate sensible strategic action plans carefully aligned with our client’s goals. Then we mobilize a coordinated effort – leverage technology and work in unison to steadfastly achieve our client’s goals without compromise in the pharmaceutical, medtech, food supplement and healthcare areas.

Our methodology includes:

  • National and international Research;
  • Applying our scientific and financial blended know-how in valuing the asset, incorporating financial and non-financial criteria, important for the pharmaceutical industry (we go beyond EBITDA):

  Technical valuation;

Post-register risk and registration asset valuation;

Site and factory valuation;

QMS valuation;

Pipeline and portfolio valuation;

Many others;

  • Implementation of valuation, teasers, management presentations, books, VDD, preliminary DDs and confirmations, as well as legal, fiscal and regulatory validation with monitoring of the deal until its completion​.